"The SCOTUS denial leaves in place lower rulings finding that the arbitration award was not against public policy because modifications to the licensing agreement separated the royalty provisions from Insall's patent rights."
"Changes to the license agreement in 1998 established a foundation for future royalty payments, reflecting how Zimmer Biomet would compensate for knee replacement technologies developed from Insall's patents."
Collection
[
|
...
]